New York State Common Retirement Fund
KROS icon

New York State Common Retirement Fund’s Keros Therapeutics KROS Stock Holding History

New York State Common Retirement Fund’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.5K Hold
9,116
– – ﹤0.01% 2703
2026
Q1 		$101K Sell
9,116
-1,500
-14% -$23.2K ﹤0.01% 2522
2025
Q4 		$216K Hold
10,616
– – ﹤0.01% 2265
2025
Q3 		$168K Hold
10,616
– – ﹤0.01% 2378
2025
Q2 		$142K Buy
10,616
+7,700
+264% +$104K ﹤0.01% 2400
2025
Q1 		$29.7K Sell
2,916
-7,400
-72% -$85.9K ﹤0.01% 2911
2024
Q4 		$163K Hold
10,316
– – ﹤0.01% 2390
2024
Q3 		$599K Sell
10,316
-2,300
-18% -$114K ﹤0.01% 1873
2024
Q2 		$577K Sell
12,616
-4,506
-26% -$242K ﹤0.01% 1984
2024
Q1 		$1.13M Buy
17,122
+6,829
+66% +$405K ﹤0.01% 1716
2023
Q4 		$409K Sell
10,293
-44
-0.4% -$1.38K ﹤0.01% 2174
2023
Q3 		$330K Buy
10,337
+92
+0.9% +$3.44K ﹤0.01% 2216
2023
Q2 		$412K Buy
10,245
+178
+2% +$7.8K ﹤0.01% 2179
2023
Q1 		$430K Sell
10,067
-2,985
-23% -$151K ﹤0.01% 2251
2022
Q4 		$627K Buy
13,052
+493
+4% +$23K ﹤0.01% 2208
2022
Q3 		$472K Buy
12,559
+1,545
+14% +$53.6K ﹤0.01% 2350
2022
Q2 		$304K Sell
11,014
-23
-0.2% -$1.01K ﹤0.01% 2595
2022
Q1 		$600K Buy
11,037
+10
+0.1% +$513 ﹤0.01% 2334
2021
Q4 		$645K Sell
11,027
-31
-0.3% -$1.55K ﹤0.01% 2308
2021
Q3 		$437K Sell
11,058
-3,244
-23% -$115K ﹤0.01% 2536
2021
Q2 		$607K Buy
14,302
+2,402
+20% +$130K ﹤0.01% 2490
2021
Q1 		$732K Buy
11,900
+800
+7% +$50.7K ﹤0.01% 2270
2020
Q4 		$783K Buy
11,100
+4,700
+73% +$296K ﹤0.01% 2148
2020
Q3 		$247K Hold
6,400
– – ﹤0.01% 2552
2020
Q2 		$240K Buy
+6,400
New +$197K ﹤0.01% 2557

Other funds holding KROS

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

New York State Common Retirement Fund's KROS Position: Q2 2026 in Review

New York State Common Retirement Fund held its Keros Therapeutics (KROS) position steady in Q2 2026 at 9,116 shares worth $97.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

New York State Common Retirement Fund first reported a position in KROS in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.13M in Q1 2024. 23 funds tracked by Wall St. Rank hold KROS as of Q2 2026.

  • New York State Common Retirement Fund held 9,116 shares of Keros Therapeutics worth $97.5K as of Q2 2026.
  • New York State Common Retirement Fund left its Keros Therapeutics share count unchanged in Q2 2026.
  • Keros Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2703 holding.
  • New York State Common Retirement Fund first reported a position in Keros Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Keros Therapeutics position peaked at $1.13M in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.